Literature DB >> 18037795

Whole-body MRI for detecting metastatic bone tumor: diagnostic value of diffusion-weighted images.

Katsuyuki Nakanishi1, Midori Kobayashi, Kazunori Nakaguchi, Miyaji Kyakuno, Nobuyuki Hashimoto, Hiromitsu Onishi, Noboru Maeda, Saki Nakata, Masatomo Kuwabara, Takamichi Murakami, Hironobu Nakamura.   

Abstract

PURPOSE: We assessed the diagnostic value of whole body magnetic resonance (MR) imaging (WB-MRI) using diffusion-weighted images (DWI) for detecting bone metastasis and compared it with that of skeletal scintigraphy (SS).
MATERIALS AND METHODS: Thirty patients with malignancies (breast cancer, 17 patients; prostate cancer, 9; and one patient each, thyroid cancer, liposarcoma, leiomyosarcoma, and extraskeletal Ewing sarcoma) underwent both WB-MRI and SS to detect bone metastasis. All patients were followed more than 6 months by MR imaging, SS, or computed tomographic (CT) examination. For WB-MRI, patients were placed in feet-first supine position with table-top extender and quadrature body coil. We acquired DWI (axial plane from lower neck to proximal femur) (single shot short TI inversion-recovery [STIR]: repetition time [TR] 6243/echo time [TE] 59/inversion time [TI] 180 ms; b value: 600 s/mm(2); 5-mm slice thickness; 112 x 112 matrix), T(1)-weighted fast spin echo (T(1)WI), and STIR (sagittal plane of total spine images and coronal plane of whole body images) images. Four blinded readers independently and separately interpreted images of combined MR sequences of T(1)WI+STIR (session 1) and T(1)WI+STIR+DWI (session 2).
RESULTS: In 10 of 30 patients, we detected a total of 52 metastatic bone lesions; in the other 20, follow-up examinations confirmed no metastatic bone lesions. For these 52 lesions, for session 2, the mean sensitivity was 96% and the positive predictive value (PPV) was 98%. Those values were superior to those of session 1 (sensitivity: 88%; PPV: 95%) and those of SS (sensitivity: 96%; PPV: 94%).
CONCLUSION: WB-MRI that included DWI was useful for detecting bone metastasis.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18037795     DOI: 10.2463/mrms.6.147

Source DB:  PubMed          Journal:  Magn Reson Med Sci        ISSN: 1347-3182            Impact factor:   2.471


  45 in total

1.  Value of diffusion-weighted magnetic resonance imaging in early diagnosis of ankylosing spondylitis.

Authors:  Fei Ai; Tao Ai; Xiaoming Li; Daoyu Hu; Wei Zhang; John N Morelli
Journal:  Rheumatol Int       Date:  2012-01-03       Impact factor: 2.631

2.  The role of magnetic resonance imaging in oncology.

Authors:  Concepción González Hernando; Laura Esteban; Teresa Cañas; Enrique Van den Brule; Miguel Pastrana
Journal:  Clin Transl Oncol       Date:  2010-09       Impact factor: 3.405

Review 3.  Diffusion-weighted (DW) and dynamic contrast-enhanced (DCE) magnetic resonance imaging (MRI) for monitoring anticancer therapy.

Authors:  Anwar R Padhani; Aftab Alam Khan
Journal:  Target Oncol       Date:  2010-04-11       Impact factor: 4.493

4.  Prospective comparison of combined 18F-FDG and 18F-NaF PET/CT vs. 18F-FDG PET/CT imaging for detection of malignancy.

Authors:  Frank I Lin; Jyotsna E Rao; Erik S Mittra; Kavitha Nallapareddy; Alka Chengapa; David W Dick; Sanjiv Sam Gambhir; Andrei Iagaru
Journal:  Eur J Nucl Med Mol Imaging       Date:  2011-11-08       Impact factor: 9.236

Review 5.  PET/MR in prostate cancer: technical aspects and potential diagnostic value.

Authors:  Michael Souvatzoglou; Matthias Eiber; Axel Martinez-Moeller; Sebastian Fürst; Konstantin Holzapfel; Tobias Maurer; Sibylle Ziegler; Stephan Nekolla; Markus Schwaiger; Ambros J Beer
Journal:  Eur J Nucl Med Mol Imaging       Date:  2013-05-24       Impact factor: 9.236

6.  [(68)Ga]DOTATATE PET/MRI and [(18)F]FDG PET/CT are complementary and superior to diffusion-weighted MR imaging for radioactive-iodine-refractory differentiated thyroid cancer.

Authors:  Alexis Vrachimis; Lars Stegger; Christian Wenning; Benjamin Noto; Matthias Christian Burg; Julia Renate Konnert; Thomas Allkemper; Walter Heindel; Burkhard Riemann; Michael Schäfers; Matthias Weckesser
Journal:  Eur J Nucl Med Mol Imaging       Date:  2016-04-08       Impact factor: 9.236

7.  Role of whole-body diffusion-weighted MRI in detecting bone metastasis.

Authors:  Riccardo Del Vescovo; Giulia Frauenfelder; Francesco Giurazza; Claudia Lucia Piccolo; Roberto Luigi Cazzato; Rosario Francesco Grasso; Emiliano Schena; Bruno Beomonte Zobel
Journal:  Radiol Med       Date:  2014-03-18       Impact factor: 3.469

Review 8.  Imaging and evaluation of patients with high-risk prostate cancer.

Authors:  Marc A Bjurlin; Andrew B Rosenkrantz; Luis S Beltran; Roy A Raad; Samir S Taneja
Journal:  Nat Rev Urol       Date:  2015-10-20       Impact factor: 14.432

9.  Types and prevalence of coexisting spine lesions on whole spine sagittal MR images in surgical degenerative spinal diseases.

Authors:  In-Ho Han; Sang-Hyun Suh; Sung-Uk Kuh; Dong-Kyu Chin; Keun Su Kim
Journal:  Yonsei Med J       Date:  2010-05       Impact factor: 2.759

10.  The role of the ADC value in the characterisation of renal carcinoma by diffusion-weighted MRI.

Authors:  B Paudyal; P Paudyal; Y Tsushima; N Oriuchi; M Amanuma; M Miyazaki; A Taketomi-Takahashi; Y Nakazato; K Endo
Journal:  Br J Radiol       Date:  2009-07-20       Impact factor: 3.039

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.